SibelBlauMD

PubMed

• Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
  Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting ...> ;Elife. 2023 Oct 17
• 5 citations
  XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormon...
  Peter Schmid, Javier Cortes, Ana Joaquim, Noelia Martínez Jañez, Serafín Morales, Tamara Díaz-Redondo, Sibel Blau, Patrick Neven, Julie Lemieux, José Ángel García-Sáen...> ;Breast Cancer Research. 2023 Jun 12
• 1 citations
  Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model.
  Sibel Blau, Julio Antonio Peguero, Halle C F Moore, Ian Churchill Anderson, Minal A Barve, Mathew Amprayil Cherian, Ahmed Elkhanany, Ciara Catherine O'Sullivan, Alvaro...> ;JCO Clinical Cancer Informatics. 2023 Jun 1
• 2 citations
  Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
  Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting ...> ;Medrxiv. 2023 Mar 10
• 22 citations
  Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COV...
  Choueiri, T., Labaki, C., Bakouny, Z., Hsu, C., Schmidt, A., de Lima Lopes, G., Hwang, C., Singh, S., Jani, C., Weissmann, L., Griffiths, E., Halabi, S., Wu, U., Berg,...> ;Lancet Regional Health. Americas. 2023 Mar 1
• 2 citations
  A real-world study to evaluate the safety and efficacy of three injectable neurokinin-1 receptor antagonist formulations for the prevention of chemotherapy-induced nau...
  George Dranitsaris, Mehdi Moezi, Kate Dobson, Robert Phelan, Sibel Blau> ;Supportive Care in Cancer. 2022 Aug 1
• 3 citations
  Impact of Augmented Intelligence on Utilization of Palliative Care Services in a Real-World Oncology Setting.
  Ajeet Gajra, Marjorie E Zettler, Kelly A Miller, John Frownfelter, John Showalter, Amy W. Valley, Sanya Sharma, Shreenath Sridharan, Jonathan Kish, Sibel Blau> ;JCO Oncology Practice. 2021 Sep 10
• Secret Sauce-How Diverse Practices Succeed in Centers for Medicare & Medicaid Services Oncology Care Model.
  Ronald M Kline, Sibel Blau, Nikolas R. Buescher, Amy R. Ellis, J. Russell Hoverman, Randall A. Oyer, Lalan S. Wilfong, Gabrielle B. Rocque> ;JCO Oncology Practice. 2021 Aug 18
• 49 citations
  Telehealth in Oncology: ASCO Standards and Practice Recommendations
  Robin Zon, Erin B. Kennedy, Kerin B. Adelson, Sibel Blau, Natalie R. Dickson, David Gill, Nicole Laferriere, Ana Maria Lopez, Therese M. Mulvey, Debra A. Patt, Todd A....> ;JCO Oncology Practice. 2021 Jul 28
• 35 citations
  Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastati...
  Rebecca Dent, Mafalda Oliveira, Steven J. Isakoff, Seock-Ah Im, Marc Espié, Sibel Blau, Antoinette R. Tan, Cristina Saura, Matthew Wongchenko, Na Xu, Denise Bradley, S...> ;Breast Cancer Research and Treatment. 2021 Jul 15
• 4 citations
  Augmented intelligence to predict 30-day mortality in patients with cancer.
  Ajeet Gajra, Marjorie E Zettler, Kelly A Miller, Sibel Blau, Swetha S Venkateshwaran, Shreenath Sridharan, John Showalter, Amy W. Valley, John Frownfelter> ;Future Oncology. 2021 Jun 30
• 39 citations
  Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2- Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1).
  Aditya Bardia, Sara A. Hurvitz, Angela DeMichele, Amy S. Clark, Amelia Zelnak, Denise A. Yardley, Meghan Sri Karuturi, Tara Sanft, Sibel Blau, Lowell L. Hart, Cynthia ...> ;Clinical Cancer Research. 2021 Aug 1
• 59 citations
  American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.
  Nathan A. Pennell, Melissa S. Dillmon, Laura A. Levit, E. Allyn Moushey, Ajjai Alva, Sibel Blau, Timothy L. Cannon, Natalie R. Dickson, Maximilian Diehn, Mithat Gonen,...> ;Journal of Clinical Oncology. 2021 Jan 10
• 65 citations
  A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO...
  Ingrid A. Mayer, Aleix Prat, Daniel Egle, Sibel Blau, J. Alejandro Perez Fidalgo, Michael Gnant, Peter A. Fasching, Marco Colleoni, Antonio C. Wolff, Eric P. Winer, Ch...> ;Clinical Cancer Research. 2019 Jan 1
• 10 citations
  Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.
  Denise A. Yardley, Lowell L. Hart, Anne Favret, Sibel Blau, Sami Diab, Donald A. Richards, Joseph A. Sparano, J. Thad Beck, Paul Richards, Patrick J. Ward, Bhuvaneswar...> ;Clinical Breast Cancer. 2019 Feb 28
• 17 citations
  Reducing Cancer Costs Through Symptom Management and Triage Pathways.
  Ronald Barkley, Mah-Jabeen Soobader, Jun Wang, Sibel Blau, Ray D. Page> ;Journal of Oncology Practice. 2019 Feb 1
• 63 citations
  Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clin...
  Guy Jerusalem, Richard De Boer, Sara A. Hurvitz, Denise A. Yardley, Elena Kovalenko, Bent Ejlertsen, Sibel Blau, Mustafa Ozguroglu, László Landherr, Marianne Ewertz, T...> ;JAMA Oncology. 2018 Oct 1
• 269 citations
  Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELL...
  Angelo Di Leo, Stephen R. D. Johnston, Keun Seok Lee, Eva Ciruelos, Per Eystein Lønning, Wolfgang Janni, Ruth O'Regan, Marie-Ange Mouret-Reynier, Dimitar Kalev, Daniel...> ;The Lancet. Oncology. 2018 Jan 1
• 30 citations
  BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid...
  Erica Gornstein, Sara Sandefur, Jon Chung, Oliver Holmes, Rachel L. Erlich, Salil Soman, L. Katherine Martin, Andrea V. Rose, Philip J. Stephens, Jeffrey S. Ross, Vinc...> ;Clinical Breast Cancer. 2017 Dec 21
• Comprehensive statistical inference of the clonal structure of cancer from multiple biopsies
  Jie Liu, John T. Halloran, Jeff A. Bilmes, Riza M. Daza, Choli Lee, Elisabeth Mahen, Donna Prunkard, Chaozhong Song, Sibel Blau, Michael O. Dorschner, Vijayakrishna K....> ;Scientific Reports. 2017 Dec 5
• 328 citations
  Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, doubl...
  Sung Bae Kim, Rebecca Dent, Seock-Ah Im, Marc Espié, Sibel Blau, Antoinette R Tan, Steven J Isakoff, Mafalda Oliveira, Cristina Saura, Matthew Wongchenko, Amy V. Kapp,...> ;The Lancet. Oncology. 2017 Oct 1
• 3 citations
  Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breas...
  Nicole M. Kuderer, Kimberly A. Burton, Sibel Blau, Francis M. Senecal, Vijayakrishna K. Gadi, S Parker, Elisabeth Mahen, David Veenstra, Josh J. Carlson, Gary H. Lyman...> ;JCO Precision Oncology. 2017 Aug 16
• 119 citations
  Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.
  Nicole M. Kuderer, Kimberly A. Burton, Sibel Blau, Andrea L. Rose, S Parker, Gary H. Lyman, C. Anthony Blau> ;JAMA Oncology. 2017 Jul 1
• 1119 citations
  Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
  Gabriel N. Hortobagyi, Salomon M. Stemmer, Howard A. Burris, Yoon Sim Yap, Gabe S. Sonke, Shani Paluch-Shimon, Mario Campone, Kimberly L. Blackwell, Fabrice Andre, Eri...> ;The New England Journal of Medicine. 2016 Oct 7
• 16 citations
  A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer
  C. Anthony Blau, Arturo Ramirez, Sibel Blau, Colin C. Pritchard, Michael O. Dorschner, Stephen C. Schmechel, Timothy J. Martins, Elisabeth Mahen, Kimberly A. Burton, V...> ;Journal of the National Comprehensive Cancer Network. 2016 Jan 1
• Join now to see all